Anti-Angiogenic Drugs Inhibit Interstitial Lung Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer

BACKGROUND: Interstitial lung disease (ILD) is the most serious complication of chemotherapy in lung cancer patients with pre-existing ILD. The effect of anti-angiogenic drugs in lung cancer patients with ILD remains unclear. We examined the effect of anti-angiogenic drugs on reducing the risk of IL...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yanning, Gong, Xiaoling, Hu, Yuxuan, Yi, Qing, Zhang, Qianning, Miao, Liyun, Zhou, Yujie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251331/
https://www.ncbi.nlm.nih.gov/pubmed/35795057
http://dx.doi.org/10.3389/fonc.2022.873709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251331/
https://www.ncbi.nlm.nih.gov/pubmed/35795057
http://dx.doi.org/10.3389/fonc.2022.873709

Ejemplares similares